Piecing Together a Broken Tumor Suppressor Phosphatase for Cancer Therapy
- PMID: 32359434
- DOI: 10.1016/j.cell.2020.04.005
Piecing Together a Broken Tumor Suppressor Phosphatase for Cancer Therapy
Abstract
Members of the PP2A family of serine/threonine phosphatases are important human tumor suppressor genes. Unlike most tumor suppressors, they are rarely mutated/deleted, but rather are impaired by "inhibitor proteins." Two papers in this issue of Cell show how some phenothiazine derivatives reactivate specific PP2A isozymes with potential benefit in cancer and other diseases.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Interests Benjamin G. Neel is the co-Founder, holds Founders equity, and receives consulting income from Navire Pharmaceuticals, which is developing SHP2 inhibitors for clinical use. He also is co-Founder, has Founders equity, and receives consulting income from Northern Biologics, Inc. He is a member of the Scientific Advisory Board and receives consulting fees and stock options from Arvinas, Inc. He has been an Expert Witness for Johnson and Johnson, Inc. in the talc litigation in U.S. Federal Court. His spouse owns equity in Arvinas, Amgen, Moderna, and Gilead Pharmaceuticals.
Comment on
-
Selective PP2A Enhancement through Biased Heterotrimer Stabilization.Cell. 2020 Apr 30;181(3):688-701.e16. doi: 10.1016/j.cell.2020.03.038. Epub 2020 Apr 20. Cell. 2020. PMID: 32315618 Free PMC article.
-
Retracted: Allosteric Activators of Protein Phosphatase 2A Display Broad Antitumor Activity Mediated by Dephosphorylation of MYBL2.Cell. 2020 Apr 30;181(3):702-715.e20. doi: 10.1016/j.cell.2020.03.051. Epub 2020 Apr 20. Cell. 2020. Retraction in: Cell. 2022 Aug 4;185(16):3058. doi: 10.1016/j.cell.2022.07.008. PMID: 32315619 Free PMC article. Retracted.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
